Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
13
RNA Quote, Financials, Valuation and Earnings
Last price:
$31.84
Seasonality move
:
38.33%
Day range:
$30.85 - $32.63
52-week range:
$8.86 - $56.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
309.49x
P/B ratio:
2.53x
Volume:
2.8M
Avg. volume:
1.4M
1-year change:
278.81%
Market cap:
$3.8B
Revenue:
$9.6M
EPS (TTM):
-$2.89
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3M | $6.8M | $9.3M | $9.2M | $9.6M | |
| Revenue Growth (YoY) | 511.87% | 192.67% | 37.41% | -1.09% | 3.64% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $14.5M | $37.6M | $101.2M | $150.4M | $191M | |
| Selling, General & Admin | $5.1M | $13.5M | $26.2M | $37.7M | $54.2M | |
| Other Inc / (Exp) | -$15K | -$75K | -$62K | -$57K | -$594K | |
| Operating Expenses | $19.7M | $51.1M | $127.4M | $188.1M | $245.2M | |
| Operating Income | -$17.3M | -$44.3M | -$118.1M | -$178.9M | -$235.6M | |
| Net Interest Expenses | $7.4M | $3K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$24.7M | -$44.4M | -$118M | -$174M | -$212.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$24.7M | -$44.4M | -$118M | -$174M | -$212.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$24.7M | -$44.4M | -$118M | -$174M | -$212.2M | |
| Basic EPS (Cont. Ops) | -$1.20 | -$2.05 | -$2.85 | -$3.34 | -$2.91 | |
| Diluted EPS (Cont. Ops) | -$1.20 | -$2.05 | -$2.85 | -$3.34 | -$2.91 | |
| Weighted Average Basic Share | $20.7M | $21.7M | $41.4M | $52.2M | $73M | |
| Weighted Average Diluted Share | $20.7M | $21.7M | $41.4M | $52.2M | $73M | |
| EBITDA | -$17M | -$43.8M | -$117.4M | -$177.5M | -$233.5M | |
| EBIT | -$17.3M | -$44.1M | -$118.1M | -$178.9M | -$235.6M | |
| Revenue (Reported) | $2.3M | $6.8M | $9.3M | $9.2M | $9.6M | |
| Operating Income (Reported) | -$17.3M | -$44.3M | -$118.1M | -$178.9M | -$235.6M | |
| Operating Income (Adjusted) | -$17.3M | -$44.1M | -$118.1M | -$178.9M | -$235.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7M | $2.2M | $2.5M | $2.8M | $2.3M | |
| Revenue Growth (YoY) | 168.62% | 23.88% | 14.75% | 13.54% | -17.1% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9.5M | $24.8M | $37.3M | $47.7M | $77.2M | |
| Selling, General & Admin | $3.8M | $6.6M | $10.1M | $13.7M | $23.3M | |
| Other Inc / (Exp) | -- | -$11K | -$12K | -$13K | -$232K | |
| Operating Expenses | $13.2M | $31.4M | $47.4M | $61.4M | $100.5M | |
| Operating Income | -$11.5M | -$29.3M | -$44.9M | -$58.6M | -$98.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$11.4M | -$29.3M | -$43.6M | -$52.4M | -$80.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$11.4M | -$29.3M | -$43.6M | -$52.4M | -$80.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.4M | -$29.3M | -$43.6M | -$52.4M | -$80.4M | |
| Basic EPS (Cont. Ops) | -$0.31 | -$0.68 | -$0.82 | -$0.71 | -$0.65 | |
| Diluted EPS (Cont. Ops) | -$0.31 | -$0.68 | -$0.82 | -$0.71 | -$0.65 | |
| Weighted Average Basic Share | $37.4M | $43.3M | $53.1M | $74.1M | $123.4M | |
| Weighted Average Diluted Share | $37.4M | $43.3M | $53.1M | $74.1M | $123.4M | |
| EBITDA | -$11.3M | -$29.1M | -$44.6M | -$58.1M | -$97.4M | |
| EBIT | -$11.4M | -$29.3M | -$44.9M | -$58.6M | -$98.1M | |
| Revenue (Reported) | $1.7M | $2.2M | $2.5M | $2.8M | $2.3M | |
| Operating Income (Reported) | -$11.5M | -$29.3M | -$44.9M | -$58.6M | -$98.1M | |
| Operating Income (Adjusted) | -$11.4M | -$29.3M | -$44.9M | -$58.6M | -$98.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.1M | $9.6M | $8.3M | $10.1M | $10.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $29.6M | $81.8M | $137.8M | $183.8M | $260.8M | |
| Selling, General & Admin | $10.5M | $23.6M | $34.8M | $48.5M | $74M | |
| Other Inc / (Exp) | -$91K | -$16K | -$85K | -$507K | -$554K | |
| Operating Expenses | $40.1M | $105.4M | $172.5M | $232.2M | $334.8M | |
| Operating Income | -$34M | -$95.8M | -$164.2M | -$222.1M | -$324.7M | |
| Net Interest Expenses | $4.4M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$38.5M | -$95.7M | -$162.1M | -$202.2M | -$280.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$38.5M | -$95.7M | -$162.1M | -$202.2M | -$280.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$38.5M | -$95.7M | -$162.1M | -$202.2M | -$280.5M | |
| Basic EPS (Cont. Ops) | -$2.24 | -$2.45 | -$4.09 | -$2.99 | -$2.89 | |
| Diluted EPS (Cont. Ops) | -$2.24 | -$2.45 | -$4.09 | -$2.99 | -$2.89 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$33.6M | -$95.2M | -$163M | -$220.2M | -$322M | |
| EBIT | -$33.9M | -$95.8M | -$164.2M | -$222.1M | -$324.7M | |
| Revenue (Reported) | $6.1M | $9.6M | $8.3M | $10.1M | $10.1M | |
| Operating Income (Reported) | -$34M | -$95.8M | -$164.2M | -$222.1M | -$324.7M | |
| Operating Income (Adjusted) | -$33.9M | -$95.8M | -$164.2M | -$222.1M | -$324.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6M | $7.5M | $6.5M | $7.4M | $7.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $24M | $68.2M | $104.8M | $138.2M | $208M | |
| Selling, General & Admin | $8.6M | $18.8M | $27.3M | $38.1M | $57.9M | |
| Other Inc / (Exp) | -$75K | -$16K | -$39K | -$489K | -$449K | |
| Operating Expenses | $32.6M | $87M | $132.1M | $176.2M | $265.9M | |
| Operating Income | -$28M | -$79.5M | -$125.7M | -$168.9M | -$257.9M | |
| Net Interest Expenses | $113K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$28.1M | -$79.5M | -$123.5M | -$151.8M | -$220M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$28.1M | -$79.5M | -$123.5M | -$151.8M | -$220M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$28.1M | -$79.5M | -$123.5M | -$151.8M | -$220M | |
| Basic EPS (Cont. Ops) | -$1.74 | -$2.02 | -$2.45 | -$2.11 | -$2.09 | |
| Diluted EPS (Cont. Ops) | -$1.74 | -$2.02 | -$2.45 | -$2.11 | -$2.09 | |
| Weighted Average Basic Share | $77M | $118.4M | $151.2M | $215.9M | $317.5M | |
| Weighted Average Diluted Share | $77M | $118.4M | $151.2M | $215.9M | $317.5M | |
| EBITDA | -$27.6M | -$79.1M | -$124.7M | -$167.4M | -$255.9M | |
| EBIT | -$27.9M | -$79.5M | -$125.7M | -$168.9M | -$257.9M | |
| Revenue (Reported) | $4.6M | $7.5M | $6.5M | $7.4M | $7.9M | |
| Operating Income (Reported) | -$28M | -$79.5M | -$125.7M | -$168.9M | -$257.9M | |
| Operating Income (Adjusted) | -$27.9M | -$79.5M | -$125.7M | -$168.9M | -$257.9M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $94.6M | $321.5M | $320.4M | $340.4M | $185.1M | |
| Short Term Investments | -- | $6.7M | $85.1M | $270.3M | $410.3M | |
| Accounts Receivable, Net | -- | -- | -- | $2.4M | $1.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $8.3M | $7.3M | |
| Other Current Assets | $1.1M | $3.5M | $5.6M | -- | -- | |
| Total Current Assets | $95.7M | $331.7M | $411.1M | $622.9M | $611.3M | |
| Property Plant And Equipment | $631K | $1.9M | $15.6M | $15M | $16.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $600K | $298K | $850K | $849K | $596K | |
| Total Assets | $96.9M | $333.9M | $427.6M | $638.8M | $628.6M | |
| Accounts Payable | -- | -- | $2.8M | $4.6M | $8.8M | |
| Accrued Expenses | -- | -- | $11.3M | $27.9M | $25.5M | |
| Current Portion Of Long-Term Debt | $2.8M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $1.8M | $3.1M | $3.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $10.2M | $14.6M | $29.7M | $51.9M | $80.7M | |
| Long-Term Debt | $1.8M | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $162.3M | $27.7M | $46.2M | $60.7M | $127.8M | |
| Common Stock | -- | $4K | $5K | $7K | $8K | |
| Other Common Equity Adj | -- | -$5K | -$187K | -$2.7M | $125K | |
| Common Equity | -$65.4M | $306.2M | $381.4M | $578.1M | $500.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$65.4M | $306.2M | $381.4M | $578.1M | $500.8M | |
| Total Liabilities and Equity | $96.9M | $333.9M | $427.6M | $638.8M | $628.6M | |
| Cash and Short Terms | $94.6M | $328.1M | $405.5M | $610.7M | $595.4M | |
| Total Debt | $4.5M | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $341.1M | $410M | $143.7M | $85.7M | $370.2M | |
| Short Term Investments | -- | $3M | $261.8M | $456.9M | $1.2B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | $14.1M | |
| Other Current Assets | $3.2M | $8.9M | $8.9M | $12.9M | -- | |
| Total Current Assets | $344.3M | $422M | $414.5M | $555.5M | $1.6B | |
| Property Plant And Equipment | $1.3M | $3.2M | $15.3M | $17M | $15.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $541K | $739K | $774K | $639K | $3.1M | |
| Total Assets | $346.1M | $425.9M | $430.5M | $573.2M | $1.6B | |
| Accounts Payable | -- | -- | -- | $5.6M | $7.7M | |
| Accrued Expenses | -- | -- | -- | $26.4M | $42M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $3.1M | $3.6M | $3.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $13.7M | $22.4M | $42.7M | $48.7M | $91.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $26M | $31M | $53.6M | $55.7M | $137.4M | |
| Common Stock | $4K | $5K | $5K | $7K | $12K | |
| Other Common Equity Adj | -- | -$1K | -$3.5M | -$1.9M | $7.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -$141.4M | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $320.2M | $394.9M | $377M | $517.5M | $1.5B | |
| Total Liabilities and Equity | $346.1M | $425.9M | $430.5M | $573.2M | $1.6B | |
| Cash and Short Terms | $341.1M | $413M | $405.5M | $542.6M | $1.6B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$24.7M | -$44.4M | -$118M | -$174M | -$212.2M | |
| Depreciation & Amoritzation | $348K | $373K | $639K | $1.4M | $2.1M | |
| Stock-Based Compensation | $406K | $4.3M | $17.1M | $27.1M | $38.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.5M | -$37.1M | -$94.8M | -$136.3M | -$119.1M | |
| Capital Expenditures | $235K | $1.1M | $3.7M | $2.8M | $4.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$235K | -$7.8M | -$82.5M | -$190M | -$130.1M | |
| Dividends Paid (Ex Special Dividend) | -$106K | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $19.5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.8M | -$4.7M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $89.2M | $272M | $176.3M | $346.2M | $93.9M | |
| Beginning Cash (CF) | $3.1M | $94.6M | $321.7M | $320.7M | $340.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $91.5M | $227.1M | -$1M | $19.9M | -$155.3M | |
| Ending Cash (CF) | $94.6M | $321.7M | $320.7M | $340.6M | $185.4M | |
| Levered Free Cash Flow | $2.3M | -$38.2M | -$98.6M | -$139.1M | -$123.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.4M | -$29.3M | -$43.6M | -$52.4M | -$80.4M | |
| Depreciation & Amoritzation | $101K | $176K | $370K | $566K | $710K | |
| Stock-Based Compensation | $1.3M | $4.6M | $7.1M | $9.8M | $14.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$9.1M | -$20.8M | -$32M | -$36.8M | -$65.6M | |
| Capital Expenditures | $845K | $800K | -$107K | $923K | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$845K | -$800K | $10.9M | -$31.5M | -$482.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.3M | -$10.5M | -- | -- | -- | |
| Cash From Financing | -$1.3M | $155.2M | $39.6M | $40K | $342.5M | |
| Beginning Cash (CF) | $352.6M | $276.7M | $125.4M | $154.2M | $578.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$11.3M | $133.6M | $18.6M | -$68.2M | -$205.6M | |
| Ending Cash (CF) | $341.3M | $410.3M | $144M | $85.9M | $373M | |
| Levered Free Cash Flow | -$10M | -$21.6M | -$31.9M | -$37.7M | -$67.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$38.5M | -$95.7M | -$162.1M | -$202.2M | -$280.5M | |
| Depreciation & Amoritzation | $341K | $546K | $1.2M | $1.9M | $2.7M | |
| Stock-Based Compensation | $2.8M | $14.4M | $24.3M | $35.7M | $47.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$29.1M | -$81.7M | -$123.3M | -$174.8M | -$184.5M | |
| Capital Expenditures | $946K | $2.3M | $3.7M | $4.2M | $4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$946K | -$5.4M | -$266.3M | -$188.9M | -$739M | |
| Dividends Paid (Ex Special Dividend) | -$106K | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$5.4M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $343.4M | $156.1M | $123.2M | $305.6M | $1.2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $313.4M | $69M | -$266.3M | -$58M | $287M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$30M | -$83.9M | -$127M | -$179M | -$188.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$28.1M | -$79.5M | -$123.5M | -$151.8M | -$220M | |
| Depreciation & Amoritzation | $258K | $431K | $1M | $1.5M | $2M | |
| Stock-Based Compensation | $2.4M | $12.5M | $19.8M | $28.4M | $37.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$24M | -$68.6M | -$97.1M | -$135.6M | -$201M | |
| Capital Expenditures | $855K | $2M | $2M | $3.4M | $3.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$855K | $1.5M | -$182.2M | -$181.1M | -$790M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$4.7M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$24M | -$10.5M | -- | -- | -- | |
| Cash From Financing | $271.6M | $155.6M | $102.5M | $62M | $1.2B | |
| Beginning Cash (CF) | $535.9M | $899.9M | $585.8M | $613.8M | $1.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $246.7M | $88.6M | -$176.7M | -$254.7M | $187.6M | |
| Ending Cash (CF) | $782.6M | $988.5M | $409.1M | $359.1M | $1.4B | |
| Levered Free Cash Flow | -$24.9M | -$70.6M | -$99.1M | -$138.9M | -$204.1M | |
Get RNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RNA
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
2.53x
1.85x
Price / LTM sales
309.49x
1.86x
Growth Metrics
RNA
Sector
Revenue growth
-17.1%
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
90.71%
8.73%
Earnings forecast
-$0.72
-$0.20
Profitability
RNA
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
-30.66%
-14.06%
Return on assets
-27.28%
-11.77%
Return on equity
-30.66%
-14.78%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Feb
28
Estimated Next Earnings Date
Feb
6
Balance Sheet
RNA
Sector
Total cash
$1.6B
$47M
Short term investments
$410.3M
$45.2M
Total assets
$628.6M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
